If you're considering GLP-1 medication for weight loss, the biggest decision you'll face is: tirzepatide or semaglutide? Both are proven to work. Both are prescribed by telehealth providers online. But they differ in how much weight you can expect to lose, what side effects to prepare for, how much they cost, and which providers offer them.
Updated March 2026 · Based on published clinical trials, FDA data, and real patient outcomes · Compare providers →
Both are injectable medications originally developed for type 2 diabetes that have shown remarkable effectiveness for weight loss. They work by mimicking natural hormones that regulate appetite and blood sugar — but they do it differently.
Activates one hormone receptor (GLP-1). Reduces appetite, slows digestion, and helps regulate blood sugar.
Activates two hormone receptors (GLP-1 and GIP). The dual action provides stronger appetite suppression and enhanced metabolic effects.
Key difference: Tirzepatide's dual-action mechanism (targeting both GLP-1 and GIP receptors) is what gives it an edge in clinical weight loss trials. Semaglutide targets only GLP-1 — still highly effective, but working through a single pathway.
| Category | Tirzepatide | Semaglutide |
|---|---|---|
| Mechanism | Dual-action: GLP-1 + GIP More advanced | Single-action: GLP-1 only |
| Average weight loss | 15-22% body weight Winner | 12-17% body weight |
| Clinical trial results | SURMOUNT: up to 22.5% loss at 72 weeks Winner | STEP: up to 16.9% loss at 68 weeks |
| 200-lb person example | Could lose 30-44 lbs More | Could lose 24-34 lbs |
| Side effects severity | Fewer severe GI effects reported Better tolerated | More nausea/vomiting at higher doses |
| Common side effects | Nausea, diarrhea, constipation | Nausea, vomiting, diarrhea, constipation |
| Dosing | Weekly injection | Weekly injection (or daily oral pill) |
| Oral option available | No (injection only) | Yes — Rybelsus® / compounded tablets More options |
| Brand-name cost (no insurance) | $1,079-1,086/month | $900-1,350/month Can be lower |
| Compounded cost | $199-399/month | $149-299/month Cheaper |
| With insurance | As low as $25/month | As low as $25/month |
| Heart protection data | Studies ongoing | FDA-approved for cardiovascular benefit Proven |
| Sleep apnea benefit | FDA-approved for sleep apnea Unique | Not approved for sleep apnea |
| Provider availability | Available at most telehealth platforms | Available everywhere — most options Wider |
| FDA weight loss approval | Yes — Zepbound® (2023) | Yes — Wegovy® (2021) |
This isn't opinion — it's published clinical data from the New England Journal of Medicine, one of the most respected medical journals in the world.
In a direct comparison study published in the New England Journal of Medicine, patients on tirzepatide 15mg lost almost twice as much weight as those on semaglutide 1mg. Weight loss did not plateau in either group at 40 weeks — meaning both medications were still working.
Important: Individual results vary. These are averages from clinical trials where participants also followed diet and exercise programs. Your results will depend on dosage, adherence, diet, exercise, and individual biology.
Both medications cause similar types of side effects — mainly gastrointestinal. But research suggests tirzepatide tends to cause fewer severe GI side effects than semaglutide, despite producing greater weight loss. This is one of its key advantages.
| Side Effect | Tirzepatide | Semaglutide |
|---|---|---|
| Nausea | Common (usually mild) | Very common |
| Vomiting | Less frequent | More frequent at higher doses |
| Diarrhea | Common | Common |
| Constipation | Common | Common |
| Decreased appetite | Expected (it's how it works) | Expected (it's how it works) |
| Injection site reactions | Mild | Mild |
| Overall GI severity | Generally milder Better | Can be more intense initially |
Pro tip: Both medications use a gradual dose-titration schedule (starting low and increasing slowly) specifically to minimize side effects. Most patients find that GI symptoms improve significantly after the first 2-4 weeks as their body adjusts.
Cost is often the deciding factor. Here's the full picture for 2026:
| Pricing Category | Tirzepatide | Semaglutide |
|---|---|---|
| Brand-name (list price) | $1,079-1,086/mo Mounjaro / Zepbound |
$900-1,350/mo Ozempic / Wegovy |
| With insurance | $25-150/mo copay | $25-150/mo copay |
| Manufacturer savings card | As low as $25/mo | As low as $25/mo |
| Compounded (telehealth) | $199-399/mo | $149-299/mo Cheaper |
| Most affordable starting price | ~$199/mo compounded | ~$129-149/mo compounded Winner |
Yes — many patients switch from semaglutide to tirzepatide (or vice versa). Common reasons include:
Your healthcare provider will guide the transition, typically starting the new medication at a lower dose to minimize side effects during the switch.
Both medications are available through online telehealth providers — no in-person visits required. Here are our top-rated options that offer both semaglutide and tirzepatide:
Tirzepatide wins on raw weight loss results and may have fewer severe side effects — but it costs more and has fewer provider options. Semaglutide wins on affordability, format options (including oral tablets), proven heart benefits, and wider availability.
The honest truth: both medications work incredibly well for weight loss. The "wrong" choice is not starting at all. Whether you begin with semaglutide or tirzepatide, you're taking a clinically proven step toward significant, lasting weight loss.
If cost is your primary concern, start with compounded semaglutide from a reputable provider. If maximum results matter most and budget is flexible, tirzepatide is the stronger option. And remember — you can always switch later if needed.
Ready to Get Started?
Compare the top-rated GLP-1 providers offering both semaglutide and tirzepatide — with pricing, reviews, and our honest assessment of each.
Compare All 10 GLP-1 Providers →Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider. Individual results may vary. Clinical trial results referenced are from published peer-reviewed studies (NEJM, SURMOUNT, STEP, SURPASS trials). Always consult a qualified physician before starting any weight loss medication. Compounded medications are not FDA-approved as finished products.
Sources